Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 134 | 134 | 135 | 135 | 134 |
| Accounts receivable | -22 | 1 | 4 | 122 | -134 |
| Accounts payable and accrued liabilities | 751 | 124 | -18 | 31 | -27 |
| Other Working Capital | 189 | 306 | 136 | 73 | -364 |
| Other Operating Activity | -1,492 | -824 | -634 | -757 | -409 |
| Operating Cash Flow | $-440 | $-259 | $-377 | $-395 | $-800 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,401 |
| Financing Cash Flow | $N/A | $N/A | $0 | $0 | $1,401 |
| Beginning Cash Position | 177 | 436 | 813 | 1,209 | 608 |
| End Cash Position | 1,386 | 177 | 436 | 813 | 1,209 |
| Net Cash Flow | $1,209 | $-259 | $-377 | $-395 | $601 |
| Free Cash Flow | |||||
| Operating Cash Flow | -440 | -259 | -377 | -395 | -800 |
| Free Cash Flow | -440 | -259 | -377 | -395 | -800 |